XCUR Stock Analysis: Buy, Sell, or Hold?
XCUR - Exicure, Inc. Common Stock
$1.62
-0.10 (-5.81%)
▼
5d:
-4.71%
30d:
-41.73%
90d:
-57.23%
WAIT
LOW Confidence
Analysis Updated: Jul 15, 2026 12:00 AM ET
Earnings: Aug 14, 2026
29d
Get Alerted When XCUR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: XCUR shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: XCUR shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: XCUR is currently trading at $1.62, which is considered oversold relative to its 30-day fair value range of $1.84 to $2.71.
Technical Outlook: Technically, XCUR is in a downtrend. The price is currently testing key support at $2.62. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 5.8% recently.
Market Sentiment: XCUR has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $2.00 (+16.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, XCUR is in a downtrend. The price is currently testing key support at $2.62. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 5.8% recently.
Market Sentiment: XCUR has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $2.00 (+16.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$1.84 -
$2.71
Company Quality Score
51/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
44.7%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BEARISH: Downward momentum (-5.8%)
- BULLISH: Trading below Wall St target ($2.00)
Trading Range Analysis
30-Day Trading Range
$1.84 -
$2.71
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$2.62
Resistance Level
$3.45
Current Trend
Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Wall Street Target
$2.00
(+16.3%)
Revenue Growth (YoY)
928.0%
Share & Embed Analysis
Last updated: July 15, 2026 4:14 PM ET
Data refreshes hourly during market hours. Next update: 5:14 PM
Data refreshes hourly during market hours. Next update: 5:14 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is XCUR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$26 | 55 HOLD |
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$413 | 57 HOLD |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$822 | 64 BUY |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 57 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$93 | 61 BUY |